Search results
Tiziana eyes orphan drug designation for multiple sclerosis treatment
Proactive Investors· 3 days agoTiziana Life Sciences Ltd (NASDAQ:TLSA) has requested its multiple sclerosis treatment be granted...
9 celebrities with multiple sclerosis who have opened up about the disease
Yahoo Canada Style· 6 days ago“I knew nothing about the disease, to be honest. I fortunately had a doctor who told me right away...
This Mother's Day, I'm celebrating the fact that I can bake with my kid again. Not long ago, that...
INSIDER via Yahoo News· 4 days agoReceiving treatment for multiple sclerosis allowed Lindsay Karp (not pictured) to start baking with...
Climate change may worsen stroke, migraine, Alzheimer's
UPI· 2 hours agoThe potential effects of a changing climate is likely to be substantial on a range of neurological...
Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
The Record Gazette· 2 days agoKyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, ...
Unlocking the body’s defences: understanding immunotherapy
The Conversation· 14 hours agoIt serves as a guardian, constantly patrolling the body to keep it safe from invaders like bacteria, viruses, and even cancer cells. Scientists are harnessing the power of the body’s natural ...
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 2 days agoThese products have the potential to address the needs of millions of patients both in...
Utah Professor Thinks She's on the Cusp of an Alzheimer's Breakthrough
The New York Sun· 2 days agoDr. Donna J. Cross, a professor at the University of Utah with a doctorate in neuroscience, thinks...
Ocrevus and interactions: Other drugs, alcohol, and more
Medical News Today· 3 days agoOcrevus (ocrelizumab) is a brand-name injection that’s prescribed for certain forms of multiple ...
Third Party Withdraws Appeal Related to Cantargia Patent
Digital Journal· 2 hours agoCantargia is listed on Nasdaq Stockholm (ticker: CANTA). More...immune suppressive tumor microenvironment and development of resistance to chemotherapy. Nadunolimab is investigated in